These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7363400)

  • 41. [Preoperative intra-arterial infusion of adriamycin in advanced breast cancer with reference to estrogen receptor status].
    Tamura G; Iwasaki T; Satodate R; Kawamura S; Kaizuka H; Abe H; Ishida M; Saito K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):263-7. PubMed ID: 3341788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer.
    Bonadonna G; Valagussa P; Tancini G; Di Fronzo G
    Cancer Chemother Pharmacol; 1980; 4(1):37-41. PubMed ID: 6988100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal receptors in locally advanced breast cancer: change with response to neoadjuvant chemotherapy?
    Morris DM; Edwards J; Gelder F
    J Surg Oncol; 1991 Mar; 46(3):156-8. PubMed ID: 2011025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability of steroid receptors in multiple biopsies of breast cancer: effect of systemic therapy.
    Lee YT
    Breast Cancer Res Treat; 1982; 2(2):185-93. PubMed ID: 7171839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of hormone receptors in the management of breast cancer--I. Advanced breast cancer.
    Cant EM; Horsfall D; Keightley DD
    Aust N Z J Surg; 1985 Apr; 55(2):121-5. PubMed ID: 3862384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
    J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
    Robertson JF; Bates K; Pearson D; Blamey RW; Nicholson RI
    Br J Cancer; 1992 May; 65(5):727-30. PubMed ID: 1534019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
    Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
    Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of oestrogen-receptor status to survival in breast cancer.
    Bishop HM; Blamey RW; Elston CW; Haybittle JL; Nicholson RI; Griffiths K
    Lancet; 1979 Aug; 2(8137):283-4. PubMed ID: 88612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of quantitative estrogen-receptor level and clinical response to cytotoxic chemotherapy in advanced breast cancer. An extramural analysis.
    Corle DK; Sears ME; Olson KB
    Cancer; 1984 Oct; 54(8):1554-61. PubMed ID: 6478397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results with tamoxifen in advanced mammary carcinoma.
    Kolb R; Jakesz R; Reiner H
    Recent Results Cancer Res; 1980; 71():146-8. PubMed ID: 7367726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?
    Barnes DM; Skinner LG; Ribeiro GG
    Br J Cancer; 1979 Dec; 40(6):862-5. PubMed ID: 230853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
    Williams MR; Todd JH; Ellis IO; Dowle CS; Haybittle JL; Elston CW; Nicholson RI; Griffiths K; Blamey RW
    Br J Cancer; 1987 Jan; 55(1):67-73. PubMed ID: 3814477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].
    Petru E; Beck K; Schünemann H; Schmähl D
    Wien Med Wochenschr; 1991; 141(7):133-5. PubMed ID: 2058160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid-hormone receptors in breast cancer.
    Wittliff JL
    Cancer; 1984 Feb; 53(3 Suppl):630-43. PubMed ID: 6692266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
    Fernández-Morales LA; Seguí MA; Andreu X; Dalmau E; Sáez A; Pericay C; Santos C; Montesinos J; Gallardo E; Arcusa A; Saigí E
    Clin Breast Cancer; 2007 Apr; 7(7):559-64. PubMed ID: 17509165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic oophorectomy in metastatic breast cancer.
    Conte CC; Nemoto T; Rosner D; Dao TL
    Cancer; 1989 Jul; 64(1):150-3. PubMed ID: 2731111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.